You are currently browsing the daily archive for July 12, 2013.

Uppsala, Sweden, July 4, 2013.  Orexo Labs  announced it has received approval from the F.D.A. for Zubsolv™ (buprenorphine/naloxone) sublingual tablet CIII.  Zubsolv is formulated for treatment for people suffering from opioid dependence

Advertisements

your views so far!

  • 113,063 site visits

CHECK OUT PAST POSTS HERE >

Twitter Feed “DadOnFire”

Archive by Month

Calendar

July 2013
M T W T F S S
« Jun   Aug »
1234567
891011121314
15161718192021
22232425262728
293031  
Advertisements